Molecular Diagnostics for Transplant Companies

ID: MRFR/MED/10305-CR

128 Pages

Rahul Gotadki

Last Updated: February 16, 2025

Molecular diagnostics for transplantation typically involves the use of genetic and molecular techniques to assess compatibility between donors and recipients, monitor transplant rejection, and optimize post-transplant care. Companies operating in this space may offer a range of products and services, including genetic testing, next-generation sequencing, and other advanced molecular diagnostic technologies.

Molecular Diagnostics for Transplant Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.91%

2024 Market Size$ 0.84 Billion

2025 Market Size$ 0.92 Billion

2035 Market Size$ 2.15 Billion

Key Players

Thermo Fisher Scientific

Roche Diagnostics

Abbott Laboratories

Qiagen

Hologic

Becton Dickinson

Trends

Technological Advancements
Regulatory Support
Personalized Medicine Focus

Opportunities

Advancements in Genomic Technologies
Rising Demand for Personalized Medicine
Increasing Prevalence of Chronic Diseases

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Molecular Diagnostics for Transplant Market

Molecular Diagnostics for Transplant Key Companies

Latest Molecular Diagnostics for Transplant Companies Update:

Natera Expanded its Prospera product line with Prospera with Quantification, the first commercially available cfDNA (cell-free DNA) test for non-invasive monitoring of kidney transplant rejection.

CareDx Received FDA approval for AlloMap Heart Care™, a next-generation gene expression test that improves the prediction of cardiac allograft vasculopathy (CAV) development after heart transplant.

Thermo Fisher Scientific Launched the TruSight Transplant One™ Kit, a comprehensive NGS (next-generation sequencing) assay enabling simultaneous analysis of HLA (human leukocyte antigen) typing, CMV (cytomegalovirus) and EBV (Epstein-Barr virus) detection, and chimerism testing in transplant patients.

List of Molecular Diagnostics for Transplant Key companies in the market

Thermo Fisher Scientific Inc. (US)
BioMérieux SA (France)
Cepheid (US)
Altona Diagnostics GmbH (Germany)
ELITechGroup (France)
Hoffmann-La Roche Ltd. (Switzerland)
Hologic Inc. (US)
QIAGEN N.V. (Germany)
Becton, Dickinson, and Company (US)
Abbott Laboratories, Inc. (US)

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”